The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published Wednesday in JAMA Psychiatry said. The study examined about 228,000 people in Sweden who had alcohol use disorder and Type 2 diabetes.

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under anesthesia.

A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol addiction. The research, published in JAMA Psychiatry, found that semaglutide and liraglutide may reduce alcohol cravings by influencing the brain's reward system.

Another day, another study linking Ozempic to major health benefits. In fact, they found it to work even better than the current most-effective drug for treating alcoholism on the market. Syda Productions – stock.

Ozempic can help with blood sugar management, aid with significant weight loss, and perhaps even treat opioid use disorder. Now, there’s one more thing to add to the list: alcohol addiction. New research finds that semaglutide medications like Ozempic and Wegovy may help to lower the risk of alcohol-related issues.